The UK leads on early stage clinical trials but falls behind Germany and the US when it comes to later-stage research.
Researchers found prescribing rates were 45 per cent higher in the most deprived populations compared to the least.
Antidepressants may reduce the risk of ischaemic stroke, Neurology reports.
Plant-based vegan diets are thought to contribute to an already low intake of an essential nutrient involved in brain health.
Printing health warnings on individual cigarettes could help reduce smoking, suggests research.
Women who use HRT are being urged to discuss its risks and benefits at their next routine appointment.
A handheld device that delivers a small electric current has been recommended in draft guidance by NICE.
Advice from pharmacists on increasing physical activity can improve the cardiovascular health of men with prostate cancer, study finds
Could a headset that delivers transcranial direct-current stimulation be the next big thing in treating depression?
Offering flu immunisation in community pharmacies increased the number of people in Wales who received the jab, report finds.
Young people are especially likely to misuse alprazolam resulting in short-term toxicity and long-term dependence, research finds.
Statins have been connected to reducing the risk of death in dementia patients, according to research presented at the EAN Congress.
E-cigarettes and varenicline are associated with higher abstinence rates than other smoking cessation aids including NRT
E-cigarettes and varenicline are associated with higher abstinence rates than other smoking cessation aids.
Women with chronic obstructive pulmonary disease are at greater risk of frequent and severe acute exacerbations than men
Two new studies confirm that psoriasis is associated with a markedly increased risk of developing mental illnesses
Almost three in every five community pharmacists have never reported an adverse drug reaction
Poor oral health has been linked to a 75 per cent increased risk of the most common form of liver cancer.
More than half of patients do not show optimal reductions in low-density lipoprotein cholesterol (LDL-C) within two years of starting statins, Heart reports
A new Canadian study reports that psychiatric conditions may emerge five years before the diagnosis of inflammatory diseases